NCT00545012View on ClinicalTrials.gov

A Safety and Efficacy Follow-up Study With Levetiracetam in Children (4-17 Years Old) Suffering From Absence Seizures

PHASE2CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

May 31, 2000

Primary Completion Date

May 31, 2003

Study Completion Date

May 31, 2003

Conditions
Absence Seizures
Interventions
DRUG

Levetiracetam

Sponsors

Lead Sponsor

UCB Pharma
All Listed Sponsors
lead

UCB Pharma

INDUSTRY